IL18 and metabolic dysfunction-associated steatotic liver disease: Mitsuyoshi reported that hepatic IL-18 mRNA and serum IL-18 levels were significantly higher in NAFLD patients than those in controls, which correlated significantly with hepatic steatosis [22].